Learn More
TARGETMOL CHEMICALS INC PKI-166 5MG

Supplier: TARGETMOL CHEMICALS INC T165495MG
Also available in 1 mg 10 mg 25 mg 50 mg 100 mg 500 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. PKI-166 is an oral inhibitor of EGF-R tyrosine kinase (IC500.7 nM) that is both effective and selective. PKI-166 can effectively inhibit the growth and metastasis of various human cancer cells including pancreatic cancer. purity: 99%
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.